Equity Overview
Price & Market Data
Price: $1.05
Daily Change: +$0.01 / 0.95%
Range: $1.04 - $1.05
Market Cap: $60,960,948
Volume: 705
Performance Metrics
1 Week: -0.95%
1 Month: 0.97%
3 Months: -19.38%
6 Months: 26.81%
1 Year: 26.83%
YTD: -5.45%
Company Details
Employees: 72
Sector: Health technology
Industry: Medical specialties
Country: Israel
Details
IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.